PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 14, 2026Physiology0 citations

Long-term changes in pulmonary function following recovery from SARS-CoV-2 infection

View Full Paper
JSJIGAR SHIJU

Key Points

  • Evaluate long-term changes in pulmonary function in individuals recovering from SARS-CoV-2 infection while assessing the impact of initial disease severity.
  • Included 196 adults aged 18-60 with documented SARS-CoV-2 PCR positivity at least 12 months prior.
  • Participants underwent pulmonary function tests using spirometry and the 6-minute walk test (6MWT).
  • Comparison of post-COVID pulmonary parameters to pre-COVID values based on initial disease severity.
  • FVC decreased from 4.04 ± 0.43 L to 3.32 ± 0.51 L, p < 0.001.
  • FEV 1 decreased from 3.26 ± 0.37 L to 2.46 ± 0.57 L, p < 0.001.
  • Patients with severe disease had a significantly lower 6-minute walk distance (511.7 ± 23.0 m vs. 577.0 ± 6.2 m, p < 0.0001).

Abstract

To evaluate long-term alterations in pulmonary function among individuals who have recovered from SARS-CoV-2 infection and to examine the association between initial disease severity and residual functional impairment. Hypothesis: Individuals recovering from SARS-CoV-2 infection demonstrate persistent abnormalities in lung volumes, airflow, and diffusion capacity ≥12 months after infection, with greater impairment in those who experienced moderate to severe disease. Methods: This observational study included 196 adults aged 18-60 years with documented SARS-CoV-2 PCR positivity at least 12 months prior. Participants with pre-existing chronic pulmonary disease or invasive ventilation were excluded. Pulmonary function testing was performed according to ATS/ERS standards using spirometry, lung volumes, and diffusing capacity measurements (FVC, FEV 1 , FEV 1 /FVC, TLC, RV, and DLCO). Functional capacity was assessed using the 6-minute walk test (6MWT). Pulmonary parameters were compared with pre-COVID values and analyzed according to disease severity. Results: Significant reductions were observed in post-COVID pulmonary function compared to pre-infection values: FVC decreased from 4.04 ± 0.43 L to 3.32 ± 0.51 L, FEV 1 from 3.26 ± 0.37 L to 2.46 ± 0.57 L, TLC from 4.66 ± 0.53 L to 3.02 ± 0.84 L, and DLCO from 8.37 ± 1.11 to 5.71 ± 1.85 mmol/kPa·min (all p < 0.001). Residual volume increased significantly, indicating air trapping. Patients with severe disease demonstrated lower 6-minute walk distance (511.7 ± 23.0 m vs. 577.0 ± 6.2 m, p < 0.0001) and significant exertional oxygen desaturation. Conclusions: Persistent impairments in lung volumes, airflow, diffusion capacity, and exercise tolerance are evident more than one year after SARS-CoV-2 infection, particularly among individuals with severe disease. These findings highlight the need for long-term pulmonary follow-up and functional assessment in post-COVID populations. Funding: None. This abstract was presented at the American Physiology Summit 2026 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

JIGAR SHIJU (2026) studied this question.

synapsesocial.com/papers/6a05661aa550a87e60a1e41bhttps://doi.org/10.1152/physiol.2026.41.s1.2347482
Ask AI
Helpful
Bookmark
Share
View Full Paper